<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: advanced</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'advanced'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22advanced%22&t=%22advanced%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 01:51:54 +0100</lastBuildDate>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=4945196&amp;cid=t_101854_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FJchz9jURj0s%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that ABC Laboratories hired Brad Benson as a senior consulting scientist in its CMC Development Services team. In his new role, he will work in program design and technical consultation for both large and small molecule drugs. Most recently, he was ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4945196</comments>
            <pubDate>Fri, 17 Jun 2011 12:15:28 +0100</pubDate>
            <guid isPermaLink="false">4945196</guid>        </item>
        <item>
            <title>Market Report: Transforming Brain Health with Digital Tools — The State of the Brain Fitness Market 2010</title>
            <link>http://www.medworm.com/index.php?rid=4570642&amp;cid=t_101854_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FSharpBrains%2F%7E3%2FqAdeoyML3gI%2F</link>
            <description>This report includes pro­pri­etary sur­veys, mar­ket data and in-depth analy­sis of 32 com­pa­nies, 10 Inno­va­tion Case Stud­ies pre­pared by 2010 Inno­va­tion Awards Win­ners and Final­ists, and 23 Research Exec­u­tive Briefs pre­pared by lead­ing scientists.
Report Sum­mary
This 207-page report tracks devel­op­ments at over thirty pub­lic and pri­vate com­pa­nies offer­ing dig­i­tal tools to assess, enhance and repair brain-based cog­ni­tive and self-regulation func­tions and pro­vides impor­tant indus­try data, insights and analy­sis to help investors, exec­u­tives, entre­pre­neurs, and pol­icy mak­ers nav­i­gate the oppor­tu­ni­ties and risks of this rapidly grow­ing field. The report dis­cusses the impli­ca­tions of cog­ni­tive ...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4570642</comments>
            <pubDate>Thu, 10 Mar 2011 16:50:17 +0100</pubDate>
            <guid isPermaLink="false">4570642</guid>        </item>
        <item>
            <title>Selecting Targeted Therapies Online: The Future Of Personalized Cancer Treatment?</title>
            <link>http://www.medworm.com/index.php?rid=4507280&amp;cid=t_101854_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fselecting-targeted-therapies-online-the-future-of-personalized-cancer-treatment%2F2011.02.22</link>
            <description>The word cancer comes from the greek word for crab “karkinos,” so named by Hippocrates who visualized the tumor and its surrounding vessels looking like a crab, dug stubbornly into the sand with its legs. We know far more about cancer today than the ancient Greeks, but the vision of an entrenched opponent, almost impossible to extract whole, appears to be vividly prescient.
What we have realized over the last half century is that removal of the visible tumor is not enough. Even as we learned how to do bigger and more destructive surgeries, the cancer still managed to sneak back in, growing later at different locations. The crab’s legs are still embedded in the patient.
Thus the discovery that certain chemicals could extinguish these rogue cells opened the modern era of cancer therapy...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4507280</comments>
            <pubDate>Tue, 22 Feb 2011 20:00:25 +0100</pubDate>
            <guid isPermaLink="false">4507280</guid>        </item>
        <item>
            <title>Provenge available for men with advanced prostate cancer at Roswell Park</title>
            <link>http://www.medworm.com/index.php?rid=4482935&amp;cid=t_101854_136_f&amp;fid=35294&amp;url=http%3A%2F%2Fwww.psa-rising.com%2Fblog%2F2011%2F02%2Fprovenge-available-for-men-with-advanced-pca-at-roswell-park%2F</link>
            <description>February 7 2011, BUFFALO, NY — The nation’s first FDA-approved cancer treatment vaccine, Provenge (sipuleucel-T), is being offered for the first time in Western New York at Roswell Park Cancer Institute (RPCI). The vaccine is designed for men with advanced prostate cancer who have limited treatment options and who meet eligibility requirements. “It’s the first [...] (Source: psa-rising.com/blog)</description>
            <author>psa-rising.com/blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4482935</comments>
            <pubDate>Wed, 16 Feb 2011 00:39:59 +0100</pubDate>
            <guid isPermaLink="false">4482935</guid>        </item>
        <item>
            <title>Outside-the-Body Filtration Device May Reduce Ovarian Cancer Cells In Abdominal Fluid</title>
            <link>http://www.medworm.com/index.php?rid=4405995&amp;cid=t_101854_136_f&amp;fid=37846&amp;url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2011%2F01%2F27%2Foutside-the-body-filtration-device-may-reduce-ovarian-cancer-cells-in-abdominal-fluid%2F</link>
            <description>A paper published in the January issue of the journal Nanomedicine could provide the foundation for a new ovarian cancer treatment option &amp;#8212; one that would use an outside-the-body filtration device to remove a large portion of the free-floating cancer cells that often create secondary tumors. A paper published in the January issue of the [...] (Source: Libby's H*O*P*E*)</description>
            <author>Libby's H*O*P*E*</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4405995</comments>
            <pubDate>Thu, 27 Jan 2011 22:13:24 +0100</pubDate>
            <guid isPermaLink="false">4405995</guid>        </item>
        <item>
            <title>Keep This Secret To Yourself!</title>
            <link>http://www.medworm.com/index.php?rid=4406053&amp;cid=t_101854_180_f&amp;fid=38607&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fsuccessbeginstoday%2FBHWQ%2F%7E3%2F6GM8rgOzRnk%2F</link>
            <description>In my last post, I talked about how to get a job promotion. It all comes down to “Making your boss look good.” The post listed books that will help you make your boss look good on paper, in numbers, and on the screen.
While making your boss look good is important, you need to keep a few things in reserve. You need your own secret weapon. While you need to make your boss look good, you need to be able to look incredible.
So how do you do this?
Here is a little known secret that can take YOUR documents, spreadsheets, and presentations to a whole new level.

Just pick up this book, download the templates, and go for it.
The author, Stephanie Krieger, helps you take your documents to the next level by using the interactive tools in Microsoft Office. She’ll show you how to take your outli...</description>
            <author>Success Begins Today</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4406053</comments>
            <pubDate>Thu, 27 Jan 2011 15:02:46 +0100</pubDate>
            <guid isPermaLink="false">4406053</guid>        </item>
        <item>
            <title>Synthetic Blood Via Artificial Cells And Platelets From Stem Cells</title>
            <link>http://www.medworm.com/index.php?rid=4372048&amp;cid=t_101854_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fsynthetic-blood-via-artificial-cells-and-platelets-from-stem-cells%2F2011.01.19</link>
            <description>There&amp;#8217;s hema­tology news, times two (at least):
1. Progress in devel­oping syn­thetic red blood cells
A University of North Carolina-Chapel Hill research group has created hydrogel par­ticles that mimic the size, shape and flex­i­bility of red blood cells (RBCs). The researchers used PRINT® (Particle Replication in Non-wetting Templates) tech­nology to gen­erate the fake RBCs, which are said to have a rel­a­tively long half-life. The findings were reported on-line yes­terday in the Proceedings of the National Academy of Sciences (PNAS) (abstract available, sub­scription required for full text). According to a PR-ish but inter­esting post on Futurity, a website put forth by a con­sortium of major research uni­ver­sities, tests of the par­ticles’ ability to ...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4372048</comments>
            <pubDate>Wed, 19 Jan 2011 14:00:47 +0100</pubDate>
            <guid isPermaLink="false">4372048</guid>        </item>
        <item>
            <title>Multiple Sclerosis and the TSA: An Open Letter to the Secretary of Homeland Security</title>
            <link>http://www.medworm.com/index.php?rid=4322594&amp;cid=t_101854_129_f&amp;fid=36038&amp;url=http%3A%2F%2Fwww.everydayhealth.com%2Fblog%2Ftrevis-life-with-multiple-sclerosis-ms%2Fmultiple-sclerosis-and-the-tsa-an-open-letter-to-the-secretary-of-homeland-security%2F</link>
            <description>Madam Secretary Napolitano,
I’m quite upset… and you should know about it (before someone far more litigious than myself tells you)!
I guess I should preface the forthcoming tirade with the fact that, as I am a proud former member of the US Coast Guard, I know very well the difficulties faced by the line employees of the Transportation Security Administration section of your Homeland Security department. I do not blame them.
I live with multiple sclerosis (MS), a degenerative disease of the central nervous system. Current research points to the body’s immune system as a possible culprit of the disease. As a result, heavy doses of corticosteroids are often employed to battle MS.
One possible side effect of such steroid use is the death of bone, which can force joint replacement. I hav...</description>
            <author>Life with MS</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4322594</comments>
            <pubDate>Fri, 07 Jan 2011 21:53:37 +0100</pubDate>
            <guid isPermaLink="false">4322594</guid>        </item>
        <item>
            <title>Australasian Resuscitation Guidelines 2011</title>
            <link>http://www.medworm.com/index.php?rid=4309618&amp;cid=t_101854_88_f&amp;fid=38129&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Flifeinthefastlane%2FWZHV%2F%7E3%2FjP9fR2-7Vhk%2F</link>
            <description>The Australian Resuscitation Council has release its 2011 resuscitation guidelines and flowcharts. (Source: Life in the Fast Lane)</description>
            <author>Life in the Fast Lane</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4309618</comments>
            <pubDate>Mon, 03 Jan 2011 12:24:24 +0100</pubDate>
            <guid isPermaLink="false">4309618</guid>        </item>
        <item>
            <title>Pfizer Sends ‘Dear Doctor’ Letter, But Not In The US</title>
            <link>http://www.medworm.com/index.php?rid=4238150&amp;cid=t_101854_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fu4s-_XNNrEI%2F</link>
            <description>Last week, Pfizer sent docs in the UK a letter warning them of the risk of osteonecrosis, or jaw bone damage, in cancer patients who are being treated with its Sutent medication and concurrent or previous use of bisphosphonates. This group of meds are taken to inhibit the loss of bone mass in people with osteoporosis and have been linked to jaw bone damage and thigh fractures (see here and here).
Sutent is used to treat advanced kidney cancer, but apparently may work to exacerbate soft-tissue damage that plays a role in causing osteonecrosis. And so far, there have been 27 cases of osteonecrosis in Sutent patients, including those in clinical trials, according to the Dear Doc letter. All totaled, about 101,400 people have been treated with Sutent between January 2006 and January 2010. 
Of ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4238150</comments>
            <pubDate>Tue, 07 Dec 2010 13:30:09 +0100</pubDate>
            <guid isPermaLink="false">4238150</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=4225658&amp;cid=t_101854_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FHWWmPeS2DuY%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is our regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Receptos hired Faheem Hasnain as ceo and president. Most recently, he was ceo and president at Facet Biotech, which was recently bought by Abbott Laboratories. Previously, he held various executive positions at PDL BioPharma, Biogen Idec, Brist...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4225658</comments>
            <pubDate>Fri, 03 Dec 2010 12:50:31 +0100</pubDate>
            <guid isPermaLink="false">4225658</guid>        </item>
        <item>
            <title>Problems with Disappearing Set Numbers in PubMed’s Clinical Queries</title>
            <link>http://www.medworm.com/index.php?rid=4077207&amp;cid=t_101854_86_f&amp;fid=38272&amp;url=http%3A%2F%2Flaikaspoetnik.wordpress.com%2F2010%2F10%2F18%2Fproblems-with-disappearing-set-numbers-in-pubmeds-clinical-queries%2F</link>
            <description>In some upcoming posts I will address various problems related to the changing interfaces of bibliographic databases. We, librarians and end users, are overwhelmed by a flood of so-called upgrades, which often fail to bring the improvements that were promised&amp;#8230;.. or which go hand-in-hand with temporary glitches. Christina of Christina&amp;#8217;s Lis Rant even made rundown of [...] (Source: Laika's MedLibLog)</description>
            <author>Laika's MedLibLog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4077207</comments>
            <pubDate>Sun, 17 Oct 2010 23:06:25 +0100</pubDate>
            <guid isPermaLink="false">4077207</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=3981017&amp;cid=t_101854_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FiQRm-u_QnZQ%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something that’s become a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that Advanced Clinical, a consulting and clinical research services firm, has hired Rosemarie Truman as executive vice president of solutions. In this role, the Oxford University graduate will be responsible for global growth...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3981017</comments>
            <pubDate>Fri, 17 Sep 2010 12:14:54 +0100</pubDate>
            <guid isPermaLink="false">3981017</guid>        </item>
        <item>
            <title>New Report Finds A Brain Health Revolution in the Making, Driven by Digital Technology and Neuroplasticity Research</title>
            <link>http://www.medworm.com/index.php?rid=3706778&amp;cid=t_101854_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FSharpBrains%2F%7E3%2FxiHveFhb7SE%2F</link>
            <description>In spite of the recent economic downturn, revenues for digital technologies to assess, enhance and treat cognition, or digital brain health and fitness tools, grew 35% in 2009. &amp;#8220;The convergence of demographic and policy trends with cognitive neuroscience discoveries and technological innovation is giving birth to a nascent marketplace that can fundamentally transform what brain health is, how it is measured, and how it is done,&amp;#8221; says Alvaro Fernandez, member of the World Economic Forum&amp;#8217;s Council on the Aging Society and Editor-in-Chief of the report. &amp;#8220;This groundbreaking report can help pioneers shape the emerging toolkit to benefit an aging society that increasingly seeks new ways to enhance cognitive functionality and mental wellness across the lifespan.&amp;#8221;
&amp;#...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3706778</comments>
            <pubDate>Mon, 28 Jun 2010 11:26:58 +0100</pubDate>
            <guid isPermaLink="false">3706778</guid>        </item>
        <item>
            <title>Another FDA Warning Letter For A J&amp;J Unit</title>
            <link>http://www.medworm.com/index.php?rid=3599741&amp;cid=t_101854_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F6tKaPU14ngw%2F</link>
            <description>No, this isn&amp;#8217;t about Tylenol or the McNeil Consumer Healthcare unit, but the healthcare giant&amp;#8217;s Advanced Sterilization Products subsidiary was cited by the FDA in a March 12 warning letter for making various adulterated devices, such as Hydrogen Peroxide Gas Plasma Sterilizers, the Sterrad CycleSure Biological Indicator, Cidex disinfectants, Cidex Test Strips and the Evotech Cleaner and Reprocessor.
What went wrong? Well, there was a &amp;#8220;failure to establish and maintain adequate procedures for verifying or validating the corrective and preventive action to ensure that such action is effective and does not adversely affect the finished devices,&amp;#8221; according to the letter. ASP failed to commit to conduct effectiveness checks on approximately 66 Sterrad units after the req...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3599741</comments>
            <pubDate>Tue, 25 May 2010 19:42:33 +0100</pubDate>
            <guid isPermaLink="false">3599741</guid>        </item>
        <item>
            <title>Advances in Dermatology Still Badly Needed</title>
            <link>http://www.medworm.com/index.php?rid=3592427&amp;cid=t_101854_160_f&amp;fid=36189&amp;url=http%3A%2F%2Fwww.skinmdblog.com%2F85%2Fadvances-in-dermatology-still-badly-needed%2F</link>
            <description>Scientists have been working to advance dermatology and make changes.  We need change, because the old “tried and true” approaches are ineffective and probably doing more harm to our skin than good.
Sometimes it seems that for every scientific conclusion, there is a contradictory one.  An example is found in treating and identifying the causes of acne.
Prior to the 1950s, dermatologists agreed that diet played a role in acne.  In particular, they blamed sugary snacks and junk food.
Research conducted in the late 1960s and early 1970s proclaimed that there was no connection between diet and acne.  Within the last couple of years, scientists have again demonstrated that there is a connection between the consumption of carbohydrates and the severity of acne.  They were also able to p...</description>
            <author>Skin MD</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3592427</comments>
            <pubDate>Mon, 24 May 2010 00:12:50 +0100</pubDate>
            <guid isPermaLink="false">3592427</guid>        </item>
        <item>
            <title>Should Craigslist Make Money Off Sex Ads? Our Poll of the Day</title>
            <link>http://www.medworm.com/index.php?rid=3511514&amp;cid=t_101854_87_f&amp;fid=36050&amp;url=http%3A%2F%2Fblisstree.com%2Flive%2Fpoll-of-the-day-should-craigslist-make-money-off-sex-ads%2F</link>
            <description>The New York Times reported yesterday that Craigslist, the popular online classifieds site, is making millions of dollars from its controversial sex advertisements. According to their article, the site is set to increase revenue by 22% in 2010 thanks to the ads, making an expected $36 million off the ads alone (Craigslist refuses to volunteer specific information, but those projections were estimated by Advanced Interactive Media Group).
The ads provoke all kinds of opponents: some who simply don&amp;#8217;t want to see sex ads when they&amp;#8217;re looking for an apartment sublet; others who argue against the moral standing of ads that sell sex services. Many human rights groups say that Craigslist has become a number one outlet used by human traffickers to sell sex services of women and girls a...</description>
            <author>Breastfeeding 1-2-3</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3511514</comments>
            <pubDate>Tue, 27 Apr 2010 21:12:21 +0100</pubDate>
            <guid isPermaLink="false">3511514</guid>        </item>
        <item>
            <title>FDA Warning: Maalox Product Mix-Ups</title>
            <link>http://www.medworm.com/index.php?rid=3283653&amp;cid=t_101854_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2FVjVjLApaBY0%2F</link>
            <description>A press release has been issued by the FDA warns consumers about possible Maalox mix-ups:
FDA Warns about Serious Side Effects from Maalox Product Mix-Ups
Maalox product maker agrees to name change to avoid confusion


The U.S. Food and Drug Administration today warned consumers about the potential for serious side effects from mistakenly using Maalox Total Relief instead of other Maalox products. The two products are intended for the relief of different symptoms and contain different active ingredients.
Maalox Total Relief is an upset stomach reliever and anti-diarrheal medication, while traditional Maalox liquid products Maalox Advanced Regular Strength and Maalox Advanced Maximum Strength are antacids. Both Maalox Total Relief and Maalox are made by Novartis Consumer Health Inc. (NCH) a...</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3283653</comments>
            <pubDate>Thu, 18 Feb 2010 00:53:14 +0100</pubDate>
            <guid isPermaLink="false">3283653</guid>        </item>
        <item>
            <title>Down’s Syndrome (trisomy 21)</title>
            <link>http://www.medworm.com/index.php?rid=3251154&amp;cid=t_101854_83_f&amp;fid=34856&amp;url=http%3A%2F%2Finsidesurgery.com%2F2010%2F02%2Fdowns-syndrome-trisomy-21%2F</link>
            <description>Pathophysiology
congenital mental retardation caused by trisomy 21 (an extra chromosome 21)
Signs and Symptoms
1) moderate mental retardation progressing to severe mental retardation (IQ of 30 in adulthood) 2) characteristic mongoloid facies &amp;#8211; flat nasal bridge, epicanthic folds, oblique palpebral fissures 3) short stature and obesity 4) spade-like hands with simian creases 5) speckled irises (Brushfield&amp;#8217;s spots) 6) hypotonia 7) congenital heart defects &amp;#8211; VSD, ASD, tetralogy of Fallot, and patent ductus arteriosus
Associated Conditions
1) increased incidence with advanced maternal age (1/30 live births at age 45 years) and previous child with Down syndrome 2) increased incidence of leukemia (especiallly ALL), Alzheimer&amp;#8217;s disease (25-50%) by age 35 years), Hirschspru...</description>
            <author>Inside Surgery</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3251154</comments>
            <pubDate>Sun, 07 Feb 2010 23:10:19 +0100</pubDate>
            <guid isPermaLink="false">3251154</guid>        </item>
        <item>
            <title>Adding Methodological Filters to MyNCBI</title>
            <link>http://www.medworm.com/index.php?rid=3033571&amp;cid=t_101854_86_f&amp;fid=38272&amp;url=http%3A%2F%2Flaikaspoetnik.wordpress.com%2F2009%2F11%2F26%2Fadding-methodological-filters-to-myncbi%2F</link>
            <description>Idea: Arnold Leenders
Text: &amp;#8220;Laika&amp;#8221;
 
Methodological Search Filters can help to narrow down a search by enriching for studies with a certain study design or methodology. PubMed has build-in methodological filters, the so called Clinical Queries for domains (like therapy and diagnosis) and for evidence based papers (like the&amp;#8220;Systematic Review subset&amp;#8221; in Pubmed). These searches are [...] (Source: Laika's MedLibLog)</description>
            <author>Laika's MedLibLog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3033571</comments>
            <pubDate>Thu, 26 Nov 2009 17:54:45 +0100</pubDate>
            <guid isPermaLink="false">3033571</guid>        </item>
        <item>
            <title>Suicide Woman Uses Do Not Resuscitate</title>
            <link>http://www.medworm.com/index.php?rid=2855527&amp;cid=t_101854_87_f&amp;fid=34872&amp;url=http%3A%2F%2Fwww.blisstree.com%2Fhealthbolt%2Fsuicide-woman-uses-do-not-resuscitate%2F</link>
            <description>Who is right?
A woman tries to commit suicide. She&amp;#8217;s rushed to the hospital but she&amp;#8217;s conscious still and hands the doctors a living will that stipulates that she doesn&amp;#8217;t want to be treated, just kept comfortable as she dies.
The doctors respect her living will and don&amp;#8217;t treat her. They feel that if they do treat her, she could come back after them later and accuse them of assault, since she specifically refused treatment. She dies.
Her family is angry, accuses the doctors of allowing the woman to die (which they did). They say, they had not choice because she told them not to. Who is right?
This did happen in the United Kingdom recently. Doctors in the UK have had directives that they were to obey living wills from people who refused treatment. Failure to comply co...</description>
            <author>Healthbolt</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2855527</comments>
            <pubDate>Thu, 01 Oct 2009 23:29:21 +0100</pubDate>
            <guid isPermaLink="false">2855527</guid>        </item>
        <item>
            <title>Update: Preparing Society for the Cognitive Age, and Industry Webinar</title>
            <link>http://www.medworm.com/index.php?rid=2699730&amp;cid=t_101854_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FSharpBrains%2F%7E3%2F-JW8Doxud-I%2F</link>
            <description>Here you have the August edition of our monthly newsletter covering cognitive health and brain fitness topics. Please remember that you can subscribe to receive this Newsletter by email, using the box at the top of this page.
Scientific publication Frontiers in Neuroscience recently published a special issue on Augmenting Cognition, and invited me to contribute with an article titled Preparing Society for the Cognitive Age. Groundbreaking brain research has occurred over the last 20 years. The opportunity to improve brain health and performance is immense, but we need to ensure the marketplace matures in a rational and sustainable manner, both through healthcare and non-healthcare channels. Click Here to read my article.
Announcements
In May 2009 SharpBrains published The State of the Bra...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2699730</comments>
            <pubDate>Thu, 13 Aug 2009 16:18:24 +0100</pubDate>
            <guid isPermaLink="false">2699730</guid>        </item>
        <item>
            <title>How To Get A Free Upgrade</title>
            <link>http://www.medworm.com/index.php?rid=2576911&amp;cid=t_101854_180_f&amp;fid=38619&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FALifeCoachsBlog%2F%7E3%2FTw5_q8jhIOk%2F</link>
            <description>I approached the Delta check-in at JFK Airport with trepidation. The lady behind the counter wasn’t laughing a lot. In fact she wasn’t laughing at all and may never have laughed in her entire life if the look on her face were anything to go by.
I mentally rehearsed what I was going to say as I neared the front of the line. I knew I needed to execute my plan with clinical precision if it were to succeed.
“Yes!” she barked.
All of a sudden my mind went blanker than Sarah Palin facing a Katie Couric question. “Er” I stammered. “Er, I was thinking that you, er&amp;#8230;er. Look, look! I can see Russia!”*
“What?!” She looked at me with a sense of agitation mixed in with the kind of momentary pity usually reserved for the bugs you clean off the front of your car. She glanced ove...</description>
            <author>Life Coach Blog: The Discomfort Zone :</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2576911</comments>
            <pubDate>Sun, 28 Jun 2009 16:52:57 +0100</pubDate>
            <guid isPermaLink="false">2576911</guid>        </item>
        <item>
            <title>&quot;Gentlemen, I Have The Pleasure Of Informing You...&quot;</title>
            <link>http://www.medworm.com/index.php?rid=2398668&amp;cid=t_101854_88_f&amp;fid=35612&amp;url=http%3A%2F%2Ftheknifeman.blogspot.com%2F2009%2F05%2Fgentlemen-i-have-pleasure-of-informing.html</link>
            <description>**For reasons that will become apparent to her, I would sugest LBF doesn't bother with this post. Her character isn't in it. I also know that now I've written this, she'll read on...**The aortic aneurysm is a pathological entity to be feared. A weakening of the walls of the aorta, the body's main artery, the original big red, if you will, allows it to stretch and swell, to bulge. Think of old school Tom and Jerry cartoons where Tom stands on a hose, and the hose swells comically behind him.Except it's less funny.I shan't bore you with the details - you'll either know them already, or not want to. But the only curative therapy is surgical, and that carries significant risk. Some cases are felt 'inoperable', or carry such high risks as to be felt inadvisable.Of course, the risk is that, like...</description>
            <author>The KnifeMan</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2398668</comments>
            <pubDate>Fri, 08 May 2009 11:24:00 +0100</pubDate>
            <guid isPermaLink="false">2398668</guid>        </item>
        <item>
            <title>Brain Fitness/ Training Report Finds Market Growth, Potential, and Confusion</title>
            <link>http://www.medworm.com/index.php?rid=2390100&amp;cid=t_101854_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FSharpBrains%2F%7E3%2FBpmMVyNz6XA%2F</link>
            <description>In this report we estimate the size of the US brain fitness software market at $265M in 2008, up from $225M in 2007 (18% annual growth), and from $100m in 2005. Two segments fuelled the market growth from 2007 to 2008: consumers (grew from $80m to $95m) and healthcare &amp;#038; insurance providers (grew from $65m to $80m).
The 150-page report finds promising research and initiatives to drive significant growth, combined with increased consumer confusion given aggressive marketing claims and lack of education and standards. The report includes:
- The complete results of an exclusive January 2009 Survey with 2,000+ respondents
- A proprietary Market &amp;#038; Research Momentum Matrix to categorize 21 key vendors into four categories
- 10 Research Executive Briefs written by leading scientists at p...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2390100</comments>
            <pubDate>Tue, 05 May 2009 00:11:54 +0100</pubDate>
            <guid isPermaLink="false">2390100</guid>        </item>
        <item>
            <title>Advanced breast cancer stages</title>
            <link>http://www.medworm.com/index.php?rid=2368315&amp;cid=t_101854_136_f&amp;fid=35300&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmetastatic-liver-cancer%2F%7E3%2FkYEVdmyI1oE%2F</link>
            <description>Having breast cancer in remission for 4 years, Heather&amp;#8217;s sister out of the blue developed advanced breast cancer stages and passed away less than 4 weeks later.
&amp;nbsp;
Her story also touches one of the most difficult questions: do we prolong life any further or do we make the journey to the next life easier?
&amp;nbsp;
What is most shocking about Heather&amp;#8217;s cancer story is the medical part though, or the lack of it. Her sister went to a hospital specialized in cancer yet Heather never mentions that the hospital found any advanced breast cancer stages.
&amp;nbsp;
Only when her sister got re-admitted in the ER, Heather talks about the cancer having spread to the liver.
&amp;nbsp;
Does this mean that when people get admitted to hospital looking yellow and having a history of cancer, nobody bot...</description>
            <author>Metastatic liver cancer</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2368315</comments>
            <pubDate>Sat, 25 Apr 2009 02:40:28 +0100</pubDate>
            <guid isPermaLink="false">2368315</guid>        </item>
        <item>
            <title>What’s Your Chronotype?  Understanding the “Lark” and “Owl” Circadian Sleep Patterns</title>
            <link>http://www.medworm.com/index.php?rid=2357552&amp;cid=t_101854_146_f&amp;fid=38266&amp;url=http%3A%2F%2Fsleepeducation.blogspot.com%2F2009%2F04%2Fwhats-your-chronotype-understanding.html</link>
            <description>A New York Times column examines the factors that contribute to your preferred sleep schedule. This is also called your “chronotype.” It turns out that your DNA has a strong influence on when you like to sleep.Some people have a circadian clock that makes them “evening types.” These “owls” have a natural tendency to stay up late at night and sleep late in the morning. Children tend to become night owls as teens because of a shift in the timing of their circadian clocks.Some night owls have delayed sleep phase disorder. This involves a struggle to conform to work or social demands. It can be difficult for them to function well during the day.Other people are natural “morning types.” These “larks” prefer to go to bed early and wake up early. Adults often become larks as t...</description>
            <author>Sleep Education</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2357552</comments>
            <pubDate>Wed, 22 Apr 2009 20:43:00 +0100</pubDate>
            <guid isPermaLink="false">2357552</guid>        </item>
        <item>
            <title>PubMed Changes at the Front Door</title>
            <link>http://www.medworm.com/index.php?rid=2305857&amp;cid=t_101854_86_f&amp;fid=38272&amp;url=http%3A%2F%2Flaikaspoetnik.wordpress.com%2F2009%2F04%2F01%2Fpubmed-changes-at-the-front-door%2F</link>
            <description>This blog has repeatedly discussed the recent and upcoming changes to PubMed (see links below). I didn&amp;#8217;t try to hide that I was not impressed with -nor very fond of- most of the changes. But despite these feelings, shared by many (librarians?), the introduced changes are there to stay, whereas the announced changes are about [...] (Source: Laika's MedLibLog)</description>
            <author>Laika's MedLibLog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2305857</comments>
            <pubDate>Wed, 01 Apr 2009 07:16:46 +0100</pubDate>
            <guid isPermaLink="false">2305857</guid>        </item>
        <item>
            <title>Advanced Neuritis in PubMed</title>
            <link>http://www.medworm.com/index.php?rid=2250033&amp;cid=t_101854_86_f&amp;fid=38272&amp;url=http%3A%2F%2Flaikaspoetnik.wordpress.com%2F2009%2F03%2F08%2Fadvanced-neuritis-in-pubmed%2F</link>
            <description>Almost a year ago (June 2008) I discussed PubMed&amp;#8217;s Advanced Search Beta in a series entitled PubMed: Past, Present and Future. At that time I was not particularly impressed by disliked Advanced Search Beta and I still do.
November last year some of its features have improved: like the addition of a Clear Button, Focused Queries, [...] (Source: Laika's MedLibLog)</description>
            <author>Laika's MedLibLog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2250033</comments>
            <pubDate>Sun, 08 Mar 2009 15:50:25 +0100</pubDate>
            <guid isPermaLink="false">2250033</guid>        </item>
        <item>
            <title>CCHIT Certification Thoughts</title>
            <link>http://www.medworm.com/index.php?rid=2152809&amp;cid=t_101854_113_f&amp;fid=34634&amp;url=http%3A%2F%2Fwww.emrandhipaa.com%2Femr-and-hipaa%2F2009%2F02%2F02%2Fcchit-certification-thoughts%2F</link>
            <description>I just came upon a blog post on the TempDev blog that talks about the expansion of CCHIT certification into a number of new specialty categories. It&amp;#8217;s really interesting to look at the list of new categories:

Behavioral Health
Clinical Research
Dermatology
Oncology
Advanced Interoperability
Advanced Quality (in reference to Quality Measures)
Advanced Clinical Decision Support
Long Term Care
OB/GYN

As noted by Ben, these are in addition to the HIE and PHR categories added for 2009. Well, I never back away from a discussion about CCHIT. I just wonder why the Senate hasn&amp;#8217;t called me up to a hearing to talk about CCHIT certification. Of course, my friend Al Borges would do much better than I, but I digress.
After reading through Ben&amp;#8217;s post about the expansion of CCHIT I had...</description>
            <author>EMR and HIPAA</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2152809</comments>
            <pubDate>Tue, 03 Feb 2009 07:35:07 +0100</pubDate>
            <guid isPermaLink="false">2152809</guid>        </item>
        <item>
            <title>Who’s afraid of the big, bad wolf?</title>
            <link>http://www.medworm.com/index.php?rid=2097957&amp;cid=t_101854_133_f&amp;fid=35129&amp;url=http%3A%2F%2Fwhitterer-autism.blogspot.com%2F2009%2F01%2Fwhos-afraid-of-big-bad-wolf.html</link>
            <description>We walk. My son has a firm grip on the “Thatcher’s” leash when a very large mastiff wanders down his own lawn towards the path. I would swear that they flinched at the same moment, my son and Thatcher. My older son cries “OH EM GEE” in a tone of doom, from a few paces behind, as his little brother yells “WHOA!” Thatcher arcs through the air like a quicksilver boomerang, sprung from the three foot lead, ricochets off a tree at seven foot to land on the ground, supine. My son launches himself on his body. They lie on the damp cold ground like spoons in a foetal position. The house owner ambles towards us with unnecessary apologies to coax his good natured, elderly hound away. As Thatcher’s whimpers subside I hear, “iz o.k.” from my son, who lies on top of the dog, arms en...</description>
            <author>Whitterer on Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2097957</comments>
            <pubDate>Tue, 13 Jan 2009 07:36:00 +0100</pubDate>
            <guid isPermaLink="false">2097957</guid>        </item>
        <item>
            <title>Daily Constitutional[s]</title>
            <link>http://www.medworm.com/index.php?rid=2096044&amp;cid=t_101854_133_f&amp;fid=35129&amp;url=http%3A%2F%2Fwhitterer-autism.blogspot.com%2F2009%2F01%2Fdaily-constitutionals.html</link>
            <description>We walk as a family, together with our dog, Thatcher. We meet and greet neighbours, old ones and new unfamiliar ones. People are friendly and make complimentary remarks about our puppy. My children offer pertinent pieces of information in return:- that he has fur, even between his toes, that the end of his tail looks like a teasel, that his poop is bigger than cat poop because he is much bigger than most cats, that the tough pads on his feet mean that he doesn’t need to wear shoes, that he smells really bad, but not as bad as the first day he arrived. Each little nugget of information is of equal worth. People seem both amused and bemused in return.By the time we dawdle back home, these cumulative exchanges appear to have percolated their psyche.“Mom?”“Yes dear?”“I like Fatcher...</description>
            <author>Whitterer on Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2096044</comments>
            <pubDate>Sun, 11 Jan 2009 07:55:00 +0100</pubDate>
            <guid isPermaLink="false">2096044</guid>        </item>
        <item>
            <title>Tidal waves</title>
            <link>http://www.medworm.com/index.php?rid=2074324&amp;cid=t_101854_133_f&amp;fid=35129&amp;url=http%3A%2F%2Fwhitterer-autism.blogspot.com%2F2009%2F01%2Ftidal-waves.html</link>
            <description>Laundry, laundry everywhere and not such much as a pair of clean undies in sight. It would appear that the world has conspired against me.  Soon a blanket ‘no clothes’ policy will be mandatory. It all starts off well and good, but during the course of the day the full hampers are emptied, although how they managed to dump it all on the Christmas tree I have no idea. The hampers become boats as they sail away down the river or careen down the stairs.My daughter and friends return from their adventure, stained with oil and mud splatters.Quite soon I shall have to adopt &quot;Nonna’s&quot; campaign. Nonna shares her room with an oversized fus ball table. Her closet and hangers are bare. Instead the handles of the game are draped with her clothing, categorized for ease of use:- worn once for a few...</description>
            <author>Whitterer on Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2074324</comments>
            <pubDate>Fri, 02 Jan 2009 07:59:00 +0100</pubDate>
            <guid isPermaLink="false">2074324</guid>        </item>
        <item>
            <title>Symptoms of advanced colon cancer</title>
            <link>http://www.medworm.com/index.php?rid=3808802&amp;cid=t_101854_136_f&amp;fid=35300&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmetastatic-liver-cancer%2F%7E3%2FknncN4nE2Nc%2F</link>
            <description>Read our clear information about symptoms of advanced colon cancer, who is at risk, what are polyps, how to prevent it and Melanie&amp;#8217;s sister&amp;#8217;s story about surviving the disease. Treatment as well as prevention is more often than not managed by a drastic change in lifestyle.
&amp;#160;
Advanced colon cancer symptoms
&amp;#160;
Colon cancer can be present for several [...] (Source: Metastatic liver cancer)</description>
            <author>Metastatic liver cancer</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3808802</comments>
            <pubDate>Fri, 19 Dec 2008 08:57:33 +0100</pubDate>
            <guid isPermaLink="false">3808802</guid>        </item>
        <item>
            <title>Sweetmaking for Transvestites</title>
            <link>http://www.medworm.com/index.php?rid=2052853&amp;cid=t_101854_133_f&amp;fid=35129&amp;url=http%3A%2F%2Fwhitterer-autism.blogspot.com%2F2008%2F12%2Fsweetmaking-for-transvestites.html</link>
            <description>I have a small confession to make about autism. When it comes to birthdays and holidays my children do not exchange gifts. My daughters often make cards and fashion presents at such times, unprompted and generally unappreciated, but even persuading the boys write their own names on a shop bought card, has proved a challenge. This fact dawns upon me one morning. I realize that we have spent our time concentrating on receiving a gift graciously, because this is a social issue with dire consequences. Whilst there can me many humiliating experiences in life, when a gift is firstly ignored, later rejected and later still, destroyed, we are aware of the hurt this causes to the giver. It effectively doubles the pain. The receiver fails to behave appropriately, the giver is mystified. In some Amer...</description>
            <author>Whitterer on Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2052853</comments>
            <pubDate>Fri, 19 Dec 2008 07:59:00 +0100</pubDate>
            <guid isPermaLink="false">2052853</guid>        </item>
        <item>
            <title>Stood up</title>
            <link>http://www.medworm.com/index.php?rid=2011197&amp;cid=t_101854_133_f&amp;fid=35129&amp;url=http%3A%2F%2Fwhitterer-autism.blogspot.com%2F2008%2F12%2Fstood-up.html</link>
            <description>Pin pricks of panic tweak my brain stem as the minutes pass, more birthday party guests arrive and there is no sign of his dad. Two hours of merriment seems more and more unlikely as friends gather to celebrate his 8th birthday at a local venue. Parents depart one by one leaving me with an assortment of 14 children, three of my own, nine special needs children and two extra siblings, just to make it that little bit more fun. I am the only adult person present and not particularly responsible.I make a dash for the back door to check it is locked and then to the front entrance where there is a youthful chap behind the till, “don’t let any of them leave!” I squeak and skuttle back to the smalls. I know for a fact that I have at least three bolters in my charge and two of them are mine!I...</description>
            <author>Whitterer on Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2011197</comments>
            <pubDate>Thu, 04 Dec 2008 07:59:00 +0100</pubDate>
            <guid isPermaLink="false">2011197</guid>        </item>
        <item>
            <title>Meet Dave</title>
            <link>http://www.medworm.com/index.php?rid=1999147&amp;cid=t_101854_133_f&amp;fid=35129&amp;url=http%3A%2F%2Fwhitterer-autism.blogspot.com%2F2008%2F11%2Fmeet-dave.html</link>
            <description>&quot;Single Sentence Movie Review.&quot;Eddie Murphy, the icon for social skills training, what not to do, how and why, with too many giggles to count.If you like what you read, send it to someone in 'need.' (Source: Whitterer on Autism)</description>
            <author>Whitterer on Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1999147</comments>
            <pubDate>Sun, 30 Nov 2008 17:51:00 +0100</pubDate>
            <guid isPermaLink="false">1999147</guid>        </item>
        <item>
            <title>Thankful for Life? Talk With Your Family About Dying - Engage with Grace</title>
            <link>http://www.medworm.com/index.php?rid=1992524&amp;cid=t_101854_118_f&amp;fid=36984&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FHealthManagementRx%2F%7E3%2F466505634%2Fthankful-for-life-talk-with-your-family.html</link>
            <description>Blogger's Note: Please. Talk with your family, friends, advocates, and caregivers about end of life choices. Do you have an advanced directive? A living will? This is *not* the kind of thing you want to leave til the last minute (literally). Live well. Engage with grace. From the Engage with Grace team: We make choices throughout our lives - where we want to live, what types of activities will fill our days, with whom we spend our time. These choices are often a balance between our desires and our means, but at the end of the day, they are decisions made with intent. But when it comes to how we want to be treated at the end our lives, often we don't express our intent or tell our loved ones about it.This has real consequences. 73% of Americans would prefer to die at home, but up to 50% die...</description>
            <author>Health Management Rx</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1992524</comments>
            <pubDate>Wed, 26 Nov 2008 18:25:00 +0100</pubDate>
            <guid isPermaLink="false">1992524</guid>        </item>
        <item>
            <title>Up And Down The Ladder… Job Changes</title>
            <link>http://www.medworm.com/index.php?rid=1981290&amp;cid=t_101854_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F460757785%2F</link>
            <description>Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share with it others. That’s right. Send us your announcements and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the layoffs. Despite the downsizing, there is movement. Here are some of the latest changes. Recognize anyone?
And here is something we hope to make a regular feature. Send us a photo and we will spotlight a different person each week. This time around, we note that PDI, a contract sales organization, hired Nancy Lurker, 50, as ceo and also appointed her to its board. Previously, Lurker was senior vp and chief marketing officer at Novartis, and before that, ceo at ImpactRx, a market...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1981290</comments>
            <pubDate>Fri, 21 Nov 2008 12:21:29 +0100</pubDate>
            <guid isPermaLink="false">1981290</guid>        </item>
        <item>
            <title>Video: Power of Attorney -  Explanation, Healthcare Directive, Duties</title>
            <link>http://www.medworm.com/index.php?rid=1975915&amp;cid=t_101854_158_f&amp;fid=36018&amp;url=http%3A%2F%2Fcaregiversbeacon.blogspot.com%2F2008%2F11%2Fvideo-power-of-attorney-in-california.html</link>
            <description>(Source: The Caregiver's Beacon - Resources, Links, Ideas, News)</description>
            <author>The Caregiver's Beacon - Resources, Links, Ideas, News</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1975915</comments>
            <pubDate>Thu, 20 Nov 2008 03:15:00 +0100</pubDate>
            <guid isPermaLink="false">1975915</guid>        </item>
        <item>
            <title>Video: Advance Healthcare Directives</title>
            <link>http://www.medworm.com/index.php?rid=1975917&amp;cid=t_101854_158_f&amp;fid=36018&amp;url=http%3A%2F%2Fcaregiversbeacon.blogspot.com%2F2008%2F11%2Fvideo-advance-healthcare-directives.html</link>
            <description>To have your healthcare wishes followed you need to have an Advance Healthcare Directive. Some people want to have as much medical care as possible if they are near the end of life, and others wish to have as little as possible. (Source: The Caregiver's Beacon - Resources, Links, Ideas, News)</description>
            <author>The Caregiver's Beacon - Resources, Links, Ideas, News</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1975917</comments>
            <pubDate>Wed, 19 Nov 2008 19:13:00 +0100</pubDate>
            <guid isPermaLink="false">1975917</guid>        </item>
        <item>
            <title>The Brain Fitness/ Training Market: An Executive Summary</title>
            <link>http://www.medworm.com/index.php?rid=1860077&amp;cid=t_101854_122_f&amp;fid=36582&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FSharpBrains%2F%7E3%2F414499048%2F</link>
            <description>Over the next weeks we are going to be sharing the Executive Summary of our market report The State of the Brain Fitness Software Market 2008 with members and clients of several partner organizations (the British Columbia Seniors Living Association, where I will be speaking this Thursday, Neurotech Reports, where I will speak on October 24th, and the Health 2.0 conference, where we are sponsoring a panel on gaming for health), so it is only fair that we first share it with our own readers.
Executive Summary
A spate of recent global news coverage on brain fitness and brain training reflects a growing interest in natural, non drug-based interventions to keep our brains sharp as we age. This interest is very timely, given an aging population, increasing prevalence of Alzheimer’s rates, ...</description>
            <author>SharpBrains</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1860077</comments>
            <pubDate>Wed, 08 Oct 2008 05:17:34 +0100</pubDate>
            <guid isPermaLink="false">1860077</guid>        </item>
        <item>
            <title>Paul Newman dies of lung cancer</title>
            <link>http://www.medworm.com/index.php?rid=1841357&amp;cid=t_101854_117_f&amp;fid=36026&amp;url=http%3A%2F%2Fblog.healthtalk.com%2Fzimney%2Fpaul-newman-dies-of-lung-cancer%2F</link>
            <description>The world mourns the loss of Paul Newman, a great actor, philanthropist and humanitarian. He was the embodiment of the Yiddish word &amp;#8220;mensch,&amp;#8221; meaning a person of great character, integrity and honor. And while it has been widely reported that his death was due to lung cancer and that he was, formerly, a heavy smoker, whether his lung cancer was caused by smoking is unknown. What is known is that smoking greatly increases one&amp;#8217;s risk of lung cancer. But what&amp;#8217;s also known is that up to 15 percent of lung cancer deaths occur in people who have never smoked. Moreover, lung cancer in never smokers is, according to the Lung Cancer Alliance, &amp;#8220;the sixth biggest cancer killer in the United States.&amp;#8221;
Over 215,000 people in the U.S. will be diagnosed with lung cancer...</description>
            <author>Dr. Z's Medical Report</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1841357</comments>
            <pubDate>Tue, 30 Sep 2008 19:22:22 +0100</pubDate>
            <guid isPermaLink="false">1841357</guid>        </item>
        <item>
            <title>For The Shrink</title>
            <link>http://www.medworm.com/index.php?rid=1688978&amp;cid=t_101854_111_f&amp;fid=34834&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FMentalNurse%2F%7E3%2F358792089%2F</link>
            <description>I saw this ad and thought of you&amp;#8230;. (Source: Mental Nurse)</description>
            <author>Mental Nurse</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1688978</comments>
            <pubDate>Thu, 07 Aug 2008 21:55:43 +0100</pubDate>
            <guid isPermaLink="false">1688978</guid>        </item>
        <item>
            <title>End of the Line for Advanced Cell Technology?</title>
            <link>http://www.medworm.com/index.php?rid=1655378&amp;cid=t_101854_87_f&amp;fid=34825&amp;url=http%3A%2F%2Fwww.wesleyjsmith.com%2Fblog%2F2008%2F07%2Fend-of-line-for-advamced-cell.html</link>
            <description>I have been very critical of Advanced Cell Technology, believing it to be a publicity seeking enterprise that used press releases to raise venture capital for morally problematic research into human cloning, ESC, the like, while at the same time, it tried to manipulate the political system to create an environment that would be conducive to it receiving taxpayer dollars. But now, that strategy may have reached the point of exhaustion. The company is apparently on the verge of going out of business. From the story: In a Securities and Exchange Commission filing Tuesday, the company warned that it doesn't have cash to continue operating after July 31 without raising additional money or drastically slashing operations. It reported $17 million in current liabilities, but only $1 million in cas...</description>
            <author>Secondhand Smoke</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1655378</comments>
            <pubDate>Fri, 25 Jul 2008 04:32:00 +0100</pubDate>
            <guid isPermaLink="false">1655378</guid>        </item>
        <item>
            <title>End of the Line for Advamced Cell Technology?</title>
            <link>http://www.medworm.com/index.php?rid=1652240&amp;cid=t_101854_87_f&amp;fid=34825&amp;url=http%3A%2F%2Fwww.wesleyjsmith.com%2Fblog%2F2008%2F07%2Fend-of-line-for-advamced-cell.html</link>
            <description>I have been very critical of Advanced Cell Technology, believing it to be a publicity seeking enterprise that used press releases to raise venture capital for morally problematic research into human cloning, ESC, the like, while at the same time, it tried to manipulate the political system to create an environment that would be conducive to it receiving taxpayer dollars. But now, that strategy may have reached the point of exhaustion. The company is apparently on the verge of going out of business. From the story: In a Securities and Exchange Commission filing Tuesday, the company warned that it doesn't have cash to continue operating after July 31 without raising additional money or drastically slashing operations. It reported $17 million in current liabilities, but only $1 million in cas...</description>
            <author>Secondhand Smoke</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1652240</comments>
            <pubDate>Fri, 25 Jul 2008 04:32:00 +0100</pubDate>
            <guid isPermaLink="false">1652240</guid>        </item>
        <item>
            <title>ImClone’s Erbitux: Approved in Japan For Colorectal Cancer Use</title>
            <link>http://www.medworm.com/index.php?rid=1637996&amp;cid=t_101854_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F339122109%2F</link>
            <description>ImClone Systems, Inc.&amp;#8217;s advanced colorectal cancer drug has now received regulatory approval in Japan.
ERBITUX(R) (cetuximab) has received marketing authorization in Japan for use in treating patients with advanced or metastatic colorectal cancer (mCRC).
Specifically, this approval allows for the use of ERBITUX to treat patients with epidermal growth factor receptor (EGFR)-positive, curatively unresectable (inoperable), advanced or recurrent CRC, and allows the use of ERBITUX plus irinotecan in second and further lines of mCRC.
With this approval, ERBITUX is the first ever EGFR-targeted monoclonal antibody to be submitted for and receive marketing authorization in Japan.
ERBITUX (cetuximab) is a monoclonal antibody (IgG1 Mab) designed to inhibit the function of a molecular structure ...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1637996</comments>
            <pubDate>Fri, 18 Jul 2008 16:00:28 +0100</pubDate>
            <guid isPermaLink="false">1637996</guid>        </item>
        <item>
            <title>Tissue Type Transglutaminase (TG2): Potential Therapeutic Target In Chemo-resistant Ovarian Cancer</title>
            <link>http://www.medworm.com/index.php?rid=1631684&amp;cid=t_101854_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F337199259%2F</link>
            <description>University of Texas M. D. Anderson Cancer Center researchers have identified tissue type transglutaminase (TG2) as potential therapeutic target in chemotherapy-resistant ovarian cancer.
&amp;#8220;&amp;#8230;.found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor cell growth and adhesion, resistance to chemotherapy and lower overall survival rates.
When researchers targeted and silenced TG2 in animal models, cancer progression was reversed, suggesting the protein may also provide a novel therapeutic approach for late-stage ovarian cancer.&amp;#8221;
Reported findings appear in the July 15th issue of Cancer Research.
Read more from UT MD Anderson Cancer Center.
Tags: chemotherapy-resistant ovarian cancer, late-stage advanced ovarian cancer, ovari...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1631684</comments>
            <pubDate>Wed, 16 Jul 2008 16:00:22 +0100</pubDate>
            <guid isPermaLink="false">1631684</guid>        </item>
        <item>
            <title>Can Our Earth Support Us As We Age?</title>
            <link>http://www.medworm.com/index.php?rid=1392492&amp;cid=t_101854_87_f&amp;fid=34872&amp;url=http%3A%2F%2Fwww.healthbolt.net%2F2008%2F04%2F22%2Fcan-our-earth-support-us-as-we-age%2F</link>
            <description>Image details: Question mark with the Earth as a dot served by picapp.com
Happy Earth Day, everyone!
We&amp;#8217;ve been reminded quite a bit today about being green and caring for our Earth. So here&amp;#8217;s my question: Can the Earth continue to care for us?!?
Over the weekend, Edna Parker of Illinois (the oldest known currently-living person) celebrated her 115th birthday. Also recently, Barbara Walters did a special on living to be 150. While this is fascinating and the idea of living past 100 sounds intriguing, when it comes right down to it, how will our world be able to support such an aging population? Here are some issues:
1. As it is, we have a dire nursing shortage. And we all know that living long doesn&amp;#8217;t always equal living well. We would need more health care professionals ...</description>
            <author>Healthbolt</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1392492</comments>
            <pubDate>Wed, 23 Apr 2008 03:04:47 +0100</pubDate>
            <guid isPermaLink="false">1392492</guid>        </item>
        <item>
            <title>Ignorance is bliss – the Good Samaritan</title>
            <link>http://www.medworm.com/index.php?rid=1389081&amp;cid=t_101854_133_f&amp;fid=35129&amp;url=http%3A%2F%2Fwhitterer-autism.blogspot.com%2F2008%2F04%2Fignorance-is-bliss-good-samaritan.html</link>
            <description>My children grow older and bigger in the cosmopolitan, open minded bliss of Silicon Valley in California. We are so used to our children that on the whole we bimble along our trajectory with only the occasional blip. Public blips usually cause me more concern that private blips. In public there is always a dilemma, should I explain and excuse, or be evasive? I feel uncomfortable announcing to perfect strangers that my boys are autistic, especially if the children are there to overhear. I wondered sometimes if this was because I was ashamed or embarrassed or both? Even now, as I think back, I believe the underlying truth was far different from such social trifles.The difficulty was the need to protect the person that you told. When you tell someone something that they are not expecting to h...</description>
            <author>Whitterer on Autism</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1389081</comments>
            <pubDate>Mon, 21 Apr 2008 18:23:00 +0100</pubDate>
            <guid isPermaLink="false">1389081</guid>        </item>
        <item>
            <title>National education and competence framework for advanced critical care practitioners</title>
            <link>http://www.medworm.com/index.php?rid=1368348&amp;cid=t_101854_86_f&amp;fid=36669&amp;url=http%3A%2F%2Ffadelibrary.wordpress.com%2F2008%2F04%2F09%2Fnational-education-and-competence-framework-for-advanced-critical-care-practitioners%2F</link>
            <description>The National education and competence framework for advanced critical care practitioners describes:


the role of an advanced critical care practitioner
how the role should function within the critical care team
the benefits of introducing the role in clinical practice 
a national framework of education and competence (Source: Fade Library)</description>
            <author>Fade Library</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1368348</comments>
            <pubDate>Wed, 09 Apr 2008 19:00:27 +0100</pubDate>
            <guid isPermaLink="false">1368348</guid>        </item>
        <item>
            <title>Advanced Prostate Cancer » Couples And Psychological Distress</title>
            <link>http://www.medworm.com/index.php?rid=1349674&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2008%2F04%2Fadvanced-prosta.html</link>
            <description>Link: Advanced Prostate Cancer » Couples And Psychological Distress. The study concluded that when a married couple deals with cancer, either partner’s psychological distress might have a significant negative impact on the other. It did nor matter which of the... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1349674</comments>
            <pubDate>Thu, 03 Apr 2008 18:39:28 +0100</pubDate>
            <guid isPermaLink="false">1349674</guid>        </item>
        <item>
            <title>News - Zoledronic Acid Safe in Men With Advanced Prostate or Renal Cancer: Presented at EAU</title>
            <link>http://www.medworm.com/index.php?rid=1340689&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2008%2F03%2Fnews---zoledron.html</link>
            <description>Link: News - Zoledronic Acid Safe in Men With Advanced Prostate or Renal Cancer: Presented at EAU. New data demonstrate a favourable safety profile for zoledronic acid in men with bone metastases from advanced hormone-refractory prostate cancer or renal cell... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1340689</comments>
            <pubDate>Tue, 01 Apr 2008 03:44:25 +0100</pubDate>
            <guid isPermaLink="false">1340689</guid>        </item>
        <item>
            <title>News - Satraplatin Shows Benefit in Prostate Cancer Patients After Docetaxel Failure: Presented at EAU</title>
            <link>http://www.medworm.com/index.php?rid=1340690&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2008%2F03%2Fnews---satrapla.html</link>
            <description>Link: News - Satraplatin Shows Benefit in Prostate Cancer Patients After Docetaxel Failure: Presented at EAU. The oral platinum satraplatin cuts the risk of disease progression and time-to-pain progression in patients with hormone-refractory prostate cancer (HRPC) who had progressed after... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1340690</comments>
            <pubDate>Tue, 01 Apr 2008 03:37:39 +0100</pubDate>
            <guid isPermaLink="false">1340690</guid>        </item>
        <item>
            <title>Introducing Charles W. Monteith MD</title>
            <link>http://www.medworm.com/index.php?rid=1909214&amp;cid=t_101854_177_f&amp;fid=38133&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FTubalReversalBlog%2F%7E3%2F320430194%2Fspecialist-tubal-reversal-dr-monteith-2.html</link>
            <description>Greetings from Dr. Monteith
My name is Dr. Charles W. Monteith and I am happy to formally introduce myself as a tubal reversal physician. I will be joining Dr. Gary Berger in practice at Chapel Hill Tubal Reversal Center as a certified tubal ligation reversal specialist in the summer of 2008. I am currently undergoing certification [...] (Source: Tubal Reversal Blog)</description>
            <author>Tubal Reversal Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909214</comments>
            <pubDate>Sun, 17 Feb 2008 22:28:39 +0100</pubDate>
            <guid isPermaLink="false">1909214</guid>        </item>
        <item>
            <title>Cancer Drug Nexavar®, Raises Blood Pressure?</title>
            <link>http://www.medworm.com/index.php?rid=1176219&amp;cid=t_101854_136_f&amp;fid=36051&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FCancerCommentary%2F%7E3%2F222582280%2F</link>
            <description>According to a study that appeared online in the January 22 issue of Lancet Oncology, patients taking Nexavar® (sorafenib) need to be carefully monitored and treated.
In clinical testing, Nexavar improved overall survival by 44 percent among people with HCC. Median overall survival was 10.7 months among those treated with the drug, versus 7.9 months among those who took a placebo. This was considered a major inroad against one of the most voracious cancers.
Nexavar is also being assessed to treat small-cell lung cancer, prostate cancer and melanoma.Earlier trials, however, had shown a 16 percent to 42.6 percent incidence of hypertension in patients taking the drug. If not properly controlled, hypertension can lead to strokes and heart attacks, as well as kidney failure.
For this paper, re...</description>
            <author>Cancer Commentary</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1176219</comments>
            <pubDate>Fri, 25 Jan 2008 00:00:41 +0100</pubDate>
            <guid isPermaLink="false">1176219</guid>        </item>
        <item>
            <title>Aspirin may interfere with treatment for advanced prostate cancer</title>
            <link>http://www.medworm.com/index.php?rid=1128883&amp;cid=t_101854_117_f&amp;fid=36026&amp;url=http%3A%2F%2Fblog.healthtalk.com%2Fzimney%2Faspirin-may-interfere-with-treatment-for-advanced-prostate-cancer%2F</link>
            <description>If you or someone you love has advanced prostate cancer and is receiving hormone treatments, it may not be wise also to be taking aspirin. That’s because of recent findings that show that for some men the aspirin, which is commonly used in low daily doses for prevention of heart attack and stroke, may result in liver toxicity, which shows itself as elevations in liver enzymes on blood tests. While this liver toxicity might not be that significant in and of itself, in men who are receiving hormone treatment for their prostate cancer with the antiandrogen drug Eulexin (flutamide), any sign of liver injury will result in its immediate discontinuation because of its known potential to cause serious liver toxicity.
The problem is that it might be the aspirin that’s causing the elevated live...</description>
            <author>Dr. Z's Medical Report</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1128883</comments>
            <pubDate>Thu, 03 Jan 2008 18:45:37 +0100</pubDate>
            <guid isPermaLink="false">1128883</guid>        </item>
        <item>
            <title>Learning About Psychiatric Advance Directives</title>
            <link>http://www.medworm.com/index.php?rid=1064203&amp;cid=t_101854_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2007%2F12%2F01%2Flearning-about-psychiatric-advance-directives%2F</link>
            <description>Last week the topic of a psychiatric advance directive, or PAD, came up in the Wall Street Journal in an article entitled, Helping Mental Patients Gain Some Control Over Treatment. A psychiatric advance directive allows a person with a mental illness to state preferences for, or dislikes of, specific treatments, designate a proxy decision-maker or make other advance decisions about their mental health care and treatment. For instance, if you know you have a bad reaction to Haldol, but may not be believed when you&amp;#8217;re in a manic or delusional state, a psychiatric advance directive helps communicate that vital information to a treatment team.
	Why wouldn&amp;#8217;t a doc just consult your medical chart for such information? Well, largely because charts are still paper and institutional or ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1064203</comments>
            <pubDate>Sun, 02 Dec 2007 00:42:06 +0100</pubDate>
            <guid isPermaLink="false">1064203</guid>        </item>
        <item>
            <title>Drugmakers Shrug At Stem Cell Breakthrough</title>
            <link>http://www.medworm.com/index.php?rid=1041884&amp;cid=t_101854_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F188255331%2F</link>
            <description>Despite excitement among some scientists - and at the White House - about an embryo-free technique for creating human stem cells, reaction from companies that might turn the research into treatments is subdued, the Associated Press reports.
In two papers published yesterday, researchers reported successfully programming ordinary human skin cells to behave like embryonic stem cells, which can theoretically be transformed into a variety of human tissues. But while biotech execs say the announcement is scientifically interesting, they also add that the new technique is even less likely to yield meaningful results soon than using embryonic cells - which requires destroying embryos.
One exec, whose company&amp;#8217;s stem-cell treatments may soon enter human clinical trials, notes that the FDAS is...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1041884</comments>
            <pubDate>Wed, 21 Nov 2007 12:33:21 +0100</pubDate>
            <guid isPermaLink="false">1041884</guid>        </item>
        <item>
            <title>Do you know what AGEs do to your blood vessels?</title>
            <link>http://www.medworm.com/index.php?rid=1030099&amp;cid=t_101854_117_f&amp;fid=34612&amp;url=http%3A%2F%2Fwww.thedoctorweighsin.com%2Fjournal%2F2007%2F11%2F15%2Fdo-you-know-what-ages-do-to-your-blood-vessels.html</link>
            <description>by Pat SalberAGEs stands for &amp;ldquo;advanced glycation end products.&amp;rdquo; AGEs are promoters of high oxidative stress and, as such, they are known to play an important role in the development of cardiovascular disease in diabetics.AGEs are produced by our bodies internally under certain conditions, such as hyperglycemia. They are also present in fairly high amounts in the typical Western diet. Research published in the Journal of the American Diet Association (Goldberg et al 2004) and in Critical Review of Food Science and Nutrition (O&amp;rsquo;Brien and Morrissey 1989), show that AGEs are present in high levels in dietary mixtures of proteins, lipids, and sugars processed under elevated temperatures, such as broiling, roasting, or grilling.According to an recent article in Diabetes Care (O...</description>
            <author>The Doctor Weighs In</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1030099</comments>
            <pubDate>Thu, 15 Nov 2007 23:07:07 +0100</pubDate>
            <guid isPermaLink="false">1030099</guid>        </item>
        <item>
            <title>The Scarlet Golf Shirt: ‘I Violated The FDCA’</title>
            <link>http://www.medworm.com/index.php?rid=999553&amp;cid=t_101854_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F178690492%2F</link>
            <description>Could this be a new fashion trend? A Birmingham, Alabama man who pleaded guilty to misdemeanor charges of violating the federal Food, Drug and Cosmetic Act has agreed to wear a yellow T-shirt or golf shirt bearing the inscription of &amp;#8220;I WAS CONVICTED OF VIOLATING THE FDCA&amp;#8221; as part of his punishment. However, he only has to wear such a shirt at seminars he must attend to learn better behavior.
Federal prosecutors say that James Lee, 62, the chief executive officer of Advanced Medical Systems, directed the manufacture of a catheter and sold the catheter without obtaining FDA approval in 2005, The Birmingham News reports. Lee was originally charged in a 12-count felony indictment. His sentence resulted from his guilty plea to two misdemeanor offenses, neither of which required any ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=999553</comments>
            <pubDate>Fri, 02 Nov 2007 11:24:49 +0100</pubDate>
            <guid isPermaLink="false">999553</guid>        </item>
        <item>
            <title>Can we control the quality of our deaths? Do advanced directives work?</title>
            <link>http://www.medworm.com/index.php?rid=868181&amp;cid=t_101854_117_f&amp;fid=34612&amp;url=http%3A%2F%2Fwww.thedoctorweighsin.com%2Fjournal%2F2007%2F9%2F13%2Fcan-we-control-the-quality-of-our-deaths-do-advanced-directi.html</link>
            <description>by Pat Salber, MDMy day began and ended thinking about &amp;ldquo;end of life&amp;rdquo; care. I am involved in a project at work to facilitate better discussions about end of life options, such as hospice and advanced directives. So, this evening, perusing the Annals of Internal Medicine (July 3, 2007), my attention was captured by a provocatively titled article, &amp;ldquo;Controlling Death: The False Promise of Advance Directives.Although published in a peer-reviewed journal, this treatise is clearly an opinion piece. Nevertheless it is thought provoking. The author, Henry Perkins, MD, from the Division of General Medicine at the University of Texas Health Science Center in San Antonio uses a single case to make his points.What he writes about this case rang true to me. He describes Mr. Jones who h...</description>
            <author>The Doctor Weighs In</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=868181</comments>
            <pubDate>Thu, 13 Sep 2007 04:09:23 +0100</pubDate>
            <guid isPermaLink="false">868181</guid>        </item>
        <item>
            <title>Neuvenge breast cancer vaccine appears safe, effective</title>
            <link>http://www.medworm.com/index.php?rid=817601&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F08%2F23%2Fneuvenge-breast-cancer-vaccine-appears-safe-effective%2F</link>
            <description>Filed under: Breast Cancer, Research, Daily newsResearchers are reporting that a new vaccine designed to treat breast cancer appears to be safe in women with advanced disease. It showed signs of slowing down tumor growth too.The Neuvenge vaccine, made by Dendreon Corporation -- maker of the Provenge prostate cancer vaccine -- targets the aggressive Her-2 positive form of breast cancer, which affects 20 to 30 percent of breast cancer patients. Using immune cells from a cancer patient's own body, Neuvenge is a tailor-made therapy.Reports about Neuvenge, published in the Journal of Clinical Oncology, indicate the vaccine did not cause any serious side effects and of the 18 women who participated in the Phase I study, there was a reduction in the size of a tumor in one patient. In three other ...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=817601</comments>
            <pubDate>Thu, 23 Aug 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">817601</guid>        </item>
        <item>
            <title>ODAC advises FDA to wait for survival data on Orplatna</title>
            <link>http://www.medworm.com/index.php?rid=811942&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F08%2Fodac-advises-fd.html</link>
            <description>Link: CancerNetwork:. Members of the Oncologic Drugs Advisory Committee (ODAC) unanimously recommended that the Food and Drug Administration delay considering the approval of Orplatna (satraplatin, GPC Biotech) until the agency receives overall survival data from the ongoing SPARC clinical trial.... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=811942</comments>
            <pubDate>Tue, 21 Aug 2007 13:11:36 +0100</pubDate>
            <guid isPermaLink="false">811942</guid>        </item>
        <item>
            <title>Tykerb for breast cancer brain metastasis</title>
            <link>http://www.medworm.com/index.php?rid=752807&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F07%2F24%2Ftykerb-for-breast-cancer-brain-metastasis%2F</link>
            <description>Filed under: Breast Cancer, Drug, Clinical TrialsTykerb (lapatinib) may be effective at shrinking breast cancer tumors in the brain, researchers say. This drug is called a targeted therapy because it can kill cancer cells and leave normal cells alone. Tykerb targets HER2 and EGFR, two proteins that function abnormally in breast cancer cells. 
A study was conducted that included 241 breast cancer patients with brain metastasis that continued to progress after radiation treatment and Herceptin therapy.
The study concluded that nearly half of the patients, 46 percent, experienced at least a twenty percent reduction in the size the the brain tumors. 
The researchers concluded &quot;Tykerb has promise in the treatment of brain metastasis&quot;. Read&amp;nbsp;|&amp;nbsp;Permalink&amp;nbsp;|&amp;nbsp;Email this&amp;nbsp;|&amp;nbs...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=752807</comments>
            <pubDate>Tue, 24 Jul 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">752807</guid>        </item>
        <item>
            <title>New Drug Fights Tough-to-Treat Prostate Cancer - Yahoo! News</title>
            <link>http://www.medworm.com/index.php?rid=734879&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F07%2Fnew-drug-fights.html</link>
            <description>Link: New Drug Fights Tough-to-Treat Prostate Cancer - Yahoo! News. The experimental drug abiraterone, which prevents testosterone production anywhere in the body, may reduce blood levels of the prostate cancer marker prostate-specific antigen (PSA) by half, new research shows... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=734879</comments>
            <pubDate>Sat, 14 Jul 2007 16:14:45 +0100</pubDate>
            <guid isPermaLink="false">734879</guid>        </item>
        <item>
            <title>Kidney cancer makes David Foster sick</title>
            <link>http://www.medworm.com/index.php?rid=699265&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F27%2Fkidney-cancer-makes-david-foster-sick%2F</link>
            <description>Filed under: Kidney Cancer, BlogsDavid Foster was diagnosed with Advanced Renal Cell Carcinoma in April 2005. Translation: stage four kidney cancer and the sixth deadliest form of cancer. Not a great disease to acquire. Also not the end of the world. Just ask David who is busy working as a National Strategic Advisor in Augusta, Georgia, headlining within the independent magazine community, hanging out with dog Gracie, and documenting his journey in a blog he calls David Foster's Kicking Kidney Cancer's Arse.He's no wimp, this guy. Just read his June 23 post, titled May kill me, but it ain't gonna beat me. He didn't let that hard-nosed kid Jerry whip him when he was eight -- he smacked him so hard in the lunchroom, Jerry was left stumbling and bleeding -- and he won't let cancer bully him e...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=699265</comments>
            <pubDate>Wed, 27 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">699265</guid>        </item>
        <item>
            <title>Advanced lung cancer and treatment drug cisplatin</title>
            <link>http://www.medworm.com/index.php?rid=675433&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F13%2Fadvanced-lung-cancer-and-treatment-drug-cisplatin%2F</link>
            <description>Filed under: Drug, Chemotherapy, Lung Cancer, Clinical Trials, ResearchA report published in the Journal of the National Cancer Institute has stated that cisplatin has better response rates than carboplatin in the treatment of advanced non-small cell lung cancer.
The two main types of lung cancer, accounting for over 90 percent of all lung cancers, are non-small cell and small cell cancer. Non-small cell lung cancer (NSCLC) accounts for most of that 90 percent.
Advanced NSCLC means that the patient's cancer has spread to other organs or areas of the body. There has been research done to evaluate which drug is better for NSCLC -- cisplatin or carboplatin. Nine clinical trials were analyzed to see what regime is a better treatment option.
 The study concluded that 30 percent of patients trea...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=675433</comments>
            <pubDate>Wed, 13 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">675433</guid>        </item>
        <item>
            <title>Interferon may improve survival in advanced liver cancer</title>
            <link>http://www.medworm.com/index.php?rid=650892&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F06%2F01%2Finterferon-may-improve-survival-in-advanced-liver-cancer%2F</link>
            <description>Filed under: Drug, Liver Cancer, Research, SurgeryInterferon is an immune stimulating agent. According to an article recently published in the Annals of Surgery, administration of interferon following surgery may improve survival among patients with advanced hepatitis B-related hepatocelluar carcinoma.
Hepatocelluar carcinoma (HCC) is the most common type of liver cancer. Unfortunately for this disease, recurrences often happen after surgical removal of the cancer. Researchers continue to evaluate ways to reduce these recurrences.
A clinical trial was conducted to evaluate the use of interferon following surgery in patients with HCC. The trial included 80 patients, one group received the interferon after surgery and the other group received no further treatment. The researchers found that ...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=650892</comments>
            <pubDate>Fri, 01 Jun 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">650892</guid>        </item>
        <item>
            <title>UroToday - AUA 2007 - Systemic Therapy of Advanced Prostate Cancer II</title>
            <link>http://www.medworm.com/index.php?rid=645289&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F05%2Furotoday_aua_20_1.html</link>
            <description>Link: UroToday - AUA 2007 - Systemic Therapy of Advanced Prostate Cancer II. This session dealt with aspects of systemic therapy of advanced disease. The impact of the PSA flare with docetaxel therapy was evaluated by Nelius and associates [... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=645289</comments>
            <pubDate>Sun, 27 May 2007 19:36:19 +0100</pubDate>
            <guid isPermaLink="false">645289</guid>        </item>
        <item>
            <title>Clodronate Does Not Improve Survival For Prostate Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=638330&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F05%2Fclodronate_does.html</link>
            <description>Link: Clodronate Does Not Improve Survival For Prostate Cancer Patients. Treatment with the drug clodronate does not improve overall survival for men with localized prostate cancer or delay the disease's progression to metastatic cancer, according to the results of a... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=638330</comments>
            <pubDate>Thu, 24 May 2007 18:27:49 +0100</pubDate>
            <guid isPermaLink="false">638330</guid>        </item>
        <item>
            <title>Living Beyond Breast Cancer: Free educational teleconference</title>
            <link>http://www.medworm.com/index.php?rid=612003&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F05%2F16%2Fliving-beyond-breast-cancer-free-educational-teleconference%2F</link>
            <description>Filed under: Breast Cancer, Chemotherapy, All Cancers, Clinical Trials, Diets, Nutrition, Services, SurgeryJoin Living Beyond Breast Cancer (LBBC) for a free educational teleconference titled Medical and Quality-of-Life Updates from the 43rd Annual Meeting of the American Society of Clinical Oncology.
The teleconference will be held on Monday, June 11, 2007 at 12:00 p.m. - 1:30 p.m. (EDT). You can participate by using any telephone or by computer using Real Network Player or Windows Media Player. Register online at www.lbbc.com or call 610-645-4567.
This teleconference brings to you groundbreaking research presented at the largest annual conference of cancer professionals in the United States. Some topics discussed will be:

  Advances in surgical, hormonal and chemotherapy treatments 
  U...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=612003</comments>
            <pubDate>Wed, 16 May 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">612003</guid>        </item>
        <item>
            <title>Dendreon's Dilemma (Provenge)- Forbes.com</title>
            <link>http://www.medworm.com/index.php?rid=620489&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F05%2Fdendreons_dilem.html</link>
            <description>Link: Dendreon's Dilemma (Provenge) - Forbes.com. Shares of Seattle biotech Dendreon plunged more than 55% in early trading Wednesday, to just over $7, after the U.S. Food and Drug Administration rejected the company's main product, Provenge. Dendreon may face years... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=620489</comments>
            <pubDate>Sat, 12 May 2007 15:45:35 +0100</pubDate>
            <guid isPermaLink="false">620489</guid>        </item>
        <item>
            <title>FDA seeks more data on cancer vaccine - Yahoo! News</title>
            <link>http://www.medworm.com/index.php?rid=620490&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F05%2Ffda_seeks_more_.html</link>
            <description>Link: FDA seeks more data on cancer vaccine - Yahoo! News. U.S. regulators demanded more data before approving a novel prostate cancer vaccine (Provenge) from Dendreon Corp.... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=620490</comments>
            <pubDate>Sat, 12 May 2007 15:35:29 +0100</pubDate>
            <guid isPermaLink="false">620490</guid>        </item>
        <item>
            <title>The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With Zoledronic Acid</title>
            <link>http://www.medworm.com/index.php?rid=620499&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F05%2Fthe_risk_of_ren_1.html</link>
            <description>Link: The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With Zoledronic Acid. Nearly one-quarter of prostate cancer (CaP) patients treated with zoledronic acid (ZA) suffer renal impairment according to a report by Dr. Oh... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=620499</comments>
            <pubDate>Thu, 10 May 2007 04:45:09 +0100</pubDate>
            <guid isPermaLink="false">620499</guid>        </item>
        <item>
            <title>Serial Markers Of Bone Turnover In Men With Metastatic Prostate Cancer Treated With Zoledronic Acid For Detection Of Bone Metastases Progression</title>
            <link>http://www.medworm.com/index.php?rid=620501&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F05%2Fserial_markers_.html</link>
            <description>Link: Serial Markers Of Bone Turnover In Men With Metastatic Prostate Cancer Treated With Zoledronic Acid For Detection Of Bone Metastases Progression. Presently, bone imaging to include bone scans is used to determine the progression of prostate cancer (CaP) metastatic... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=620501</comments>
            <pubDate>Thu, 10 May 2007 04:41:39 +0100</pubDate>
            <guid isPermaLink="false">620501</guid>        </item>
        <item>
            <title>Locally advanced breast cancer: Chemo before surgery</title>
            <link>http://www.medworm.com/index.php?rid=589131&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F05%2F04%2Flocally-advanced-breast-cancer-chemo-before-surgery%2F</link>
            <description>Filed under: Breast Cancer, Drug, Chemotherapy, Clinical Trials, Research, SurgeryChemotherapy given before surgery to remove cancer is called neoadjuvant treatment. An oncologist might recommend this based of the size of the tumor -- it being very large. The idea is to shrink the tumor and then have surgery to remove the cancer.
Having chemotherapy administered while the tumor is still there can show what drugs are working and what drugs have no effect on the tumor. Chemotherapy when started immediately, not after surgery with healing time needed, gives the patient systematic treatment right away. This could be beneficial and is why physicians might recommend this form of treatment. The truth is they don't know if it is better or not.
Of course, every case of breast cancer is different. W...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=589131</comments>
            <pubDate>Fri, 04 May 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">589131</guid>        </item>
        <item>
            <title>The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With Zoledronic Acid</title>
            <link>http://www.medworm.com/index.php?rid=585595&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F05%2Fthe_risk_of_ren.html</link>
            <description>Link: The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With Zoledronic Acid. The Risk Of Renal Impairment In Hormone-Refractory Prostate Cancer Patients With Bone Metastases Treated With Zoledronic Acid... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=585595</comments>
            <pubDate>Tue, 01 May 2007 18:46:36 +0100</pubDate>
            <guid isPermaLink="false">585595</guid>        </item>
        <item>
            <title>Thought for the Day: Could money have been everything?</title>
            <link>http://www.medworm.com/index.php?rid=576862&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F04%2F29%2Fthought-for-the-day-money-isnt-everything-or-could-it-have-be%2F</link>
            <description>Filed under: Lung Cancer, Daily news, Thought for the DayThere's so much more to life than money. At the same time, the daily grind definitely depends some on this coveted staple. For one man, whose life did depend on money, it could have been everything. But it wasn't.Think about this:Wayne Schenk won $1 million in the New York lottery on January 12 after purchasing a $5 scratch-off ticket. His jackpot win came just five weeks after his diagnosis of inoperable lung cancer was delivered. His one wish: to receive a lump sum so he could receive specialized treatment for his advanced disease.Lottery officials claim they were sympathetic but just couldn't give him a lump sum. The best they could do was issue him $50,000 annual installments for 20 years. Schenk, 51, only survived for a little m...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=576862</comments>
            <pubDate>Sun, 29 Apr 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">576862</guid>        </item>
        <item>
            <title>UroToday - PSA Doubling Predicts Prostate Cancer Recurrence</title>
            <link>http://www.medworm.com/index.php?rid=551850&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F04%2Furotoday_psa_do.html</link>
            <description>Link: UroToday - PSA Doubling Predicts Prostate Cancer Recurrence. A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time (DT)... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=551850</comments>
            <pubDate>Wed, 18 Apr 2007 16:13:40 +0100</pubDate>
            <guid isPermaLink="false">551850</guid>        </item>
        <item>
            <title>Prostate Cancer Progression In The Presence Of Undetectable Or Low Serum Prostate-Specific Antigen Level</title>
            <link>http://www.medworm.com/index.php?rid=551853&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F04%2Fprostate_cancer.html</link>
            <description>Link: Prostate Cancer Progression In The Presence Of Undetectable Or Low Serum Prostate-Specific Antigen Level. Patients treated with definitive therapy for prostate cancer (CaP) are reassured that a low or undetectable PSA means the absence of metastatic disease. However, exceptions... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=551853</comments>
            <pubDate>Wed, 18 Apr 2007 16:01:35 +0100</pubDate>
            <guid isPermaLink="false">551853</guid>        </item>
        <item>
            <title>Method to screen prostate cancer less effective</title>
            <link>http://www.medworm.com/index.php?rid=551856&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F04%2Fmethod_to_scree.html</link>
            <description>Link: Method to screen prostate cancer less effective. A common method used to diagnose localised prostate cancer, one of the more common cancers among men, may be less effective than previously believed, researchers at Sweden's Karolinska Institutet said.... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=551856</comments>
            <pubDate>Wed, 18 Apr 2007 15:56:26 +0100</pubDate>
            <guid isPermaLink="false">551856</guid>        </item>
        <item>
            <title>Yoga good for the soul and breast cancer too</title>
            <link>http://www.medworm.com/index.php?rid=548569&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F04%2F17%2Fyoga-good-for-the-soul-and-breast-cancer-too%2F</link>
            <description>This study offers the first, small-scale evidence for yoga's potential benefits for women with limited life expectancy.Read&amp;nbsp;|&amp;nbsp;Permalink&amp;nbsp;|&amp;nbsp;Email this&amp;nbsp;|&amp;nbsp;Linking&amp;nbsp;Blogs&amp;nbsp;|&amp;nbsp;Comments (Source: The Cancer Blog)</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=548569</comments>
            <pubDate>Tue, 17 Apr 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">548569</guid>        </item>
        <item>
            <title>New Imaging Method Shows Whether Treatment For Advanced Prostate Cancer Is Working</title>
            <link>http://www.medworm.com/index.php?rid=546961&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F04%2Fnew_imaging_met.html</link>
            <description>Link: ScienceDaily: New Imaging Method Shows Whether Treatment For Advanced Prostate Cancer Is Working. Researchers at the University of Michigan Comprehensive Cancer Center have identified a new imaging technique that can measure the effectiveness of treatment for prostate cancer that... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=546961</comments>
            <pubDate>Mon, 16 Apr 2007 18:10:13 +0100</pubDate>
            <guid isPermaLink="false">546961</guid>        </item>
        <item>
            <title>Working through cancer treatments</title>
            <link>http://www.medworm.com/index.php?rid=541235&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F04%2F13%2Fworking-through-cancer-treatments%2F</link>
            <description>Filed under: Breast Cancer, Chemotherapy, Celebrity cancer diagnosis, All Cancers, Opinion, Cancer SurvivorsIn the news there has been a lot of questioning whether or not it is wise for someone diagnosed with cancer, and needs therapy or treatments to control their cancer, should still work or carry on with their life the way it was before cancer entered into their lives.
Its a good question -- but all cancer survivors or patients must make this decision themselves and should not be judged either way. Treatments can be physically mild or debilitating and everywhere in between. 
I know women who are walking in Elizabeth Edward's shoes and have metastatic breast cancer. These women that I know might not be blazing the campaign trail but they are still keepin-on- keepin-on with life like it w...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=541235</comments>
            <pubDate>Fri, 13 Apr 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">541235</guid>        </item>
        <item>
            <title>PSA level does not adequately predict 'lethal' prostate cancer risk</title>
            <link>http://www.medworm.com/index.php?rid=523781&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F04%2Fpsa_level_does_.html</link>
            <description>Link: PSA level does not adequately predict 'lethal' prostate cancer risk. A new study has found that prostate-specific antigen (PSA) levels in a man's bloodstream is not a sufficient indicator of prostate cancer diagnosis, nor does its rate of change... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=523781</comments>
            <pubDate>Thu, 05 Apr 2007 16:22:49 +0100</pubDate>
            <guid isPermaLink="false">523781</guid>        </item>
        <item>
            <title>Thought for the Day: Three signs of ovarian cancer</title>
            <link>http://www.medworm.com/index.php?rid=522848&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F04%2F05%2Fthought-for-the-day-three-signs-of-ovarian-cancer%2F</link>
            <description>Filed under: Ovarian Cancer, Research, Daily news, Thought for the DayOvarian cancer is difficult to detect. There are no great screening tests to pick up on its presence in the body, and by the time symptoms appear, the disease has often progressed into an advanced stage. But a ray of light has recently emerged in the study of ovarian cancer -- and it could help in the prevention and early detection of this deadly disease.Think about this, from the April 2007 issue of Woman's Day magazine:Researchers at the University of Washington School of Medicine have identified a simple checklist of six symptoms associated with an increased risk of the disease and three of them -- if they occur at least 12 times per month and are present for less than one year -- were present 57 percent of the time i...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=522848</comments>
            <pubDate>Thu, 05 Apr 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">522848</guid>        </item>
        <item>
            <title>Using Vitamin D to Treat Prostate Cancer</title>
            <link>http://www.medworm.com/index.php?rid=519657&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F04%2Fusing_vitamin_d.html</link>
            <description>Link: Using Vitamin D to Treat Prostate Cancer. Our bodies make vitamin D naturally when exposed to the sun, but each new, high potency, vitamin D pill contains an extraordinary amount.... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=519657</comments>
            <pubDate>Wed, 04 Apr 2007 03:19:09 +0100</pubDate>
            <guid isPermaLink="false">519657</guid>        </item>
        <item>
            <title>FDA Panel Backs Prostate Cancer Vaccine - Yahoo! News</title>
            <link>http://www.medworm.com/index.php?rid=511651&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F03%2Ffda_panel_backs.html</link>
            <description>Link: FDA Panel Backs Prostate Cancer Vaccine - Yahoo! News. A U.S. Food and Drug Administration advisory panel voted Thursday to support approval of Provenge, a vaccine aimed at extending survival for patients with deadly metastatic prostate cancer... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=511651</comments>
            <pubDate>Fri, 30 Mar 2007 20:39:49 +0100</pubDate>
            <guid isPermaLink="false">511651</guid>        </item>
        <item>
            <title>United Press International - Health Business - Statins lower prostate cancer risk?</title>
            <link>http://www.medworm.com/index.php?rid=495903&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F03%2Funited_press_in.html</link>
            <description>Link: United Press International - Health Business - Statins lower prostate cancer risk?. A U.S. epidemiologic study released this week suggests men who use statin drugs may cut in half the risk of advanced prostate cancer.... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=495903</comments>
            <pubDate>Fri, 23 Mar 2007 16:10:24 +0100</pubDate>
            <guid isPermaLink="false">495903</guid>        </item>
        <item>
            <title>Weekly Docetaxel And Prednisolone Versus Prednisolone Alone In Androgen-Independent Prostate Cancer: A Randomized Phase II Study</title>
            <link>http://www.medworm.com/index.php?rid=495925&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F03%2Fweekly_docetaxe.html</link>
            <description>Link: Weekly Docetaxel And Prednisolone Versus Prednisolone Alone In Androgen-Independent Prostate Cancer: A Randomized Phase II Study. UroToday.com- In 2004 two large randomized clinical trials demonstrated that docetaxel based chemotherapy improved survival in androgen-independent prostate cancer (AICAP). In combination with... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=495925</comments>
            <pubDate>Thu, 22 Mar 2007 01:04:08 +0100</pubDate>
            <guid isPermaLink="false">495925</guid>        </item>
        <item>
            <title>Study Of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel In Androgen-Independent Prostate Cancer</title>
            <link>http://www.medworm.com/index.php?rid=495935&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F03%2Fstudy_of_highdo.html</link>
            <description>Link: Study Of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel In Androgen-Independent Prostate Cancer. UroToday.com- Calcitriol (1, 25-dihydroxycholecalciferol), the natural ligand of the vitamin D receptor, has been shown to possess antitumor activity in preclinical prostate cancer models.... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=495935</comments>
            <pubDate>Thu, 22 Mar 2007 00:56:40 +0100</pubDate>
            <guid isPermaLink="false">495935</guid>        </item>
        <item>
            <title>Inflammation plays key role in the metastasis of prostate cancer</title>
            <link>http://www.medworm.com/index.php?rid=495941&amp;cid=t_101854_136_f&amp;fid=35293&amp;url=http%3A%2F%2Fprostate-help.blogs.com%2Fprostatehelp%2F2007%2F03%2Finflammation_pl.html</link>
            <description>Link: Inflammation plays key role in the metastasis of prostate cancer. Now, research at the University of California, San Diego (UCSD) School of Medicine strongly suggests that inflammation associated with the progression of tumors actually plays a key role in... (Source: Prostate-Help)</description>
            <author>Prostate-Help</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=495941</comments>
            <pubDate>Thu, 22 Mar 2007 00:52:37 +0100</pubDate>
            <guid isPermaLink="false">495941</guid>        </item>
        <item>
            <title>Breast cancer drug Tykerb wins FDA approval</title>
            <link>http://www.medworm.com/index.php?rid=478736&amp;cid=t_101854_87_f&amp;fid=34865&amp;url=http%3A%2F%2Fwww.thecancerblog.com%2F2007%2F03%2F13%2Fbreast-cancer-drug-tykerb-wins-fda-approval%2F</link>
            <description>Filed under: Breast Cancer, Drug, Daily newsTykerb has been approved by the FDA for use in conjunction with the chemotherapy drug Xeloda. Tykerb is a cancer medication that more precisely targets tumors without killing lots of healthy cells in the process.
Herceptin and Tykerb target a protein called HER-2/neu but work in different ways. Herceptin targets the outside of the HER2 protein and Tykerb works from the inside of the cell. This difference can give advanced breast cancer patients another drug to switch to if Herceptin stops working for them.
Glaxo said that Tykerb will be available in two weeks. The results of a study showed that Tykerb worked so well that the international study was stopped early and all the participants were offered the drug.
The FDA said it was too early to know...</description>
            <author>The Cancer Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=478736</comments>
            <pubDate>Tue, 13 Mar 2007 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">478736</guid>        </item>
    </channel>
</rss>

